Sara Majocchi

Sara Majocchi is a Discovery Program Leader at Light Chain Bioscience, with expertise in developing innovative therapeutic bispecific antibodies using the κλ body platform, contributing to both internal and partnered projects since 2013. In previous roles, Sara was a scientist involved in oncology projects, focusing on pre-clinical development. Academic qualifications include a PhD in Biotechnology from the University of Lausanne, where research contributed to epigenetic regulatory elements, and a Master of Science in Biotechnology from Ecole Supérieure de Biotechnologie de Strasbourg. Sara’s extensive experience spans multiple research institutions, including the German Cancer Research Center and internships in biotechnology labs.